These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32283971)

  • 1. Active Surveillance of the Implantable Cardioverter-Defibrillator Registry for Defibrillator Lead Failures.
    Resnic FS; Majithia A; Dhruva SS; Ssemaganda H; Robbins S; Marinac-Dabic D; Hewitt K; Ohno-Machado L; Reynolds MR; Matheny ME
    Circ Cardiovasc Qual Outcomes; 2020 Apr; 13(4):e006105. PubMed ID: 32283971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Evaluation of Biotronik Linox and Linox(smart) Implantable Cardioverter Defibrillator Leads.
    Good ED; Cakulev I; Orlov MV; Hirsh D; Simeles J; Mohr K; Moll P; Bloom H
    J Cardiovasc Electrophysiol; 2016 Jun; 27(6):735-42. PubMed ID: 26990515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early ICD lead failure in defibrillator systems with multiple leads via cephalic access.
    Barbhaiya CR; Niazi O; Bostrom J; Patil S; Jankelson L; Bernstein S; Park D; Holmes D; Aizer A; Chinitz LA
    J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1462-1469. PubMed ID: 32356380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term performance and lead failure analysis of the Durata defibrillation lead compared to its previous model, the recalled Riata defibrillation lead.
    Kleemann T; Nonnenmacher F; Strauss M; Kouraki K; Werner N; Fendt A; Zahn R
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):2012-2019. PubMed ID: 31332876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of outcomes and required tools between transvenous extraction of pacemaker and implantable cardioverter defibrillator leads: Insight from single high-volume center experience.
    Hayashi K; Callahan T; Rickard J; Baranowski B; Martin DO; Nakhla S; Tabaja C; Paul A; Wilkoff BL
    J Cardiovasc Electrophysiol; 2024 Jul; 35(7):1382-1392. PubMed ID: 38725252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-coil and dual-coil defibrillator leads and association with clinical outcomes in a complete Danish nationwide ICD cohort.
    Larsen JM; Hjortshøj SP; Nielsen JC; Johansen JB; Petersen HH; Haarbo J; Johansen MB; Thøgersen AM
    Heart Rhythm; 2016 Mar; 13(3):706-12. PubMed ID: 26593333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.
    Khazanie P; Hellkamp AS; Fonarow GC; Bhatt DL; Masoudi FA; Anstrom KJ; Heidenreich PA; Yancy CW; Curtis LH; Hernandez AF; Peterson ED; Al-Khatib SM
    J Am Heart Assoc; 2015 Aug; 4(8):e002061. PubMed ID: 26251283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Use of Primary-Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients With Heart Failure: A Prospective Propensity Score-Matched Analysis From the Swedish Heart Failure Registry.
    Schrage B; Uijl A; Benson L; Westermann D; Ståhlberg M; Stolfo D; Dahlström U; Linde C; Braunschweig F; Savarese G
    Circulation; 2019 Nov; 140(19):1530-1539. PubMed ID: 31476893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic fluoroscopic and electrical assessment of implantable cardioverter-defibrillator patients implanted with silicone-polyurethane copolymer (Optim™) coated leads.
    Forleo GB; Di Biase L; Panattoni G; Politano A; Magliano G; Santini L; Natale A; Romeo F
    Europace; 2014 Feb; 16(2):265-70. PubMed ID: 24042736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of the Durata implantable cardioverter defibrillator lead: results of an independent multicenter study.
    Rordorf R; Taravelli E; Forleo GB; Giannola G; Calzolari V; Tadeo G; Rossi S; Vicentini A; Curnis A; Serra P; Santamaria M; Calò L
    J Cardiovasc Med (Hagerstown); 2019 Oct; 20(10):676-681. PubMed ID: 31343450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis.
    Nakhoul GN; Schold JD; Arrigain S; Harb SC; Jolly S; Wilkoff BL; Nally JV; Navaneethan SD
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1119-27. PubMed ID: 26111859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and early clinical outcomes of patients undergoing totally subcutaneous vs. transvenous single chamber implantable cardioverter defibrillator placement.
    Mithani AA; Kath H; Hunter K; Andriulli J; Ortman M; Field J; Russo AM
    Europace; 2018 Feb; 20(2):308-314. PubMed ID: 28383717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, implications, and management of sense-B-noise failure in subcutaneous cardioverter-defibrillator patients: insights from a large multicentre registry.
    Wörmann J; Strik M; Jurisic S; Stout K; Elrefai M; Becher N; Schaer B; van Stipdonk A; Srinivasan NT; Ploux S; Breitenstein A; Kron J; Roberts PR; Toennis T; Linz D; Dulai R; Hermes-Laufer J; Koneru J; Erküner Ö; Dittrich S; van den Bruck JH; Schipper JH; Sultan A; Rosenberger KD; Steven D; Lüker J
    Europace; 2024 Jun; 26(6):. PubMed ID: 38861398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac perforation from implantable cardioverter-defibrillator lead placement: insights from the national cardiovascular data registry.
    Hsu JC; Varosy PD; Bao H; Dewland TA; Curtis JP; Marcus GM
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):582-90. PubMed ID: 24002030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and outcomes of diabetic patients with an implantable cardioverter defibrillator in a real world setting: results from the Israeli ICD registry.
    Steiner H; Geist M; Goldenberg I; Suleiman M; Glikson M; Tenenbaum A; Swissa M; Fisman EZ; Golovchiner G; Strasberg B; Barsheshet A;
    Cardiovasc Diabetol; 2016 Dec; 15(1):160. PubMed ID: 27905927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications in recipients of cardioverter-defibrillator or cardiac resynchronization therapy: Insights from Silesian Center Defibrillator registry.
    Tajstra M; Gadula-Gacek E; Kurek A; Adamowicz-Czoch E; Olszowski D; Ostręga M; Ciślak A; Pyka Ł; Hawranek M; Lekston A; Poloński L; Gąsior M
    Cardiol J; 2017; 24(5):515-522. PubMed ID: 27734455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procedural outcomes and long-term survival following trans-venous defibrillator lead extraction in patients with end-stage renal disease.
    Shah AD; Peddareddy LP; Addish MA; Kelly K; Patel AU; Casey M; Goyal A; Leon AR; El-Chami MF; Merchant FM
    Europace; 2017 Dec; 19(12):1994-2000. PubMed ID: 28065887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.
    Almehmadi F; Porta-Sánchez A; Ha ACT; Fischer HD; Wang X; Austin PC; Lee DS; Nanthakumar K
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.
    Gadler F; Valzania C; Linde C
    Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.